Our Vision:
A world where every myeloma patient can live life to the fullest,
unburdened by the disease.
I am a...
About Multiple Myeloma
Multiple myeloma starts in the bone marrow plasma cells. It weakens the immune system and can affect many parts of the body by causing the bone marrow to create dysfunctional antibodies and plasma cells. Living with or treating this disease means making complicated decisions, and this requires searching for reliable, current information on multiple myeloma.
How Can the International Myeloma Foundation Help?
The International Myeloma Foundation (IMF) connects people to what matters most — research that pushes the field forward, education that clarifies complex topics, support tailored to individual needs, and advocacy that amplifies every voice. Patients, care partners, healthcare professionals, and researchers can access the knowledge, resources, and community they need from the IMF to navigate life with myeloma.
In this week’s blog, IMF Chief Medical Officer Dr. Joseph Mikhael tackles the top takeaways from the recently concluded annual meetings of the International Myeloma Working Group (IMWG), the American Society of Clinical Oncology (ASCO), and the European Hematology Association (EHA). Dr. Mikhael breaks down and summarizes the top takeaways — ones that hold the greatest impact for patients with myeloma. Read the blog and find out more about the latest developments in myeloma research and treatments — taken from some of the biggest and most prominent annual meetings of myeloma experts this year. READ THE BLOG.
For 35 years, the International Myeloma Foundation (IMF) has been the heartbeat of the myeloma community. Our history is filled with the stories of those touched by myeloma. We see you—not just as a patient—but as a son, as a daughter, a husband, a wife, a parent, or a grandparent.
This GivingTuesday, we realize you have many causes to choose to support. We ask you to make a choice that matters to the myeloma community. No gift is too small. Give today up until December 2, 2025, to help us reach our goal of $100,000 funds raised for those living with myeloma and their loved ones. GIVE NOW.
The International Myeloma Foundation (IMF) is excited to announce that the 2026 Boca Raton Patient and Family Seminar will take place on March 13-14, 2026, in Boca Raton, Florida. The seminar is FREE, but in-person seating is LIMITED. LEARN MORE.
On November 6, 2025, according to an FDA press release, "the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-risk smoldering multiple myeloma (SMM)." READ THE PRESS RELEASE.
Each year, the IMF hosts an IMWG Conference Series: Making Sense of Treatment webinar. For this year's webinar, join us virtually on Wednesday, December 17, 2025, at 3:00 p.m. PST | 4:00 p.m. MT | 5:00 p.m. CT | 6:00 p.m. ET. Learn more and register at this link: REGISTER NOW.
The International Myeloma Foundation (IMF) hosts a thirty-minute Facebook livestream on December 8, 2025, at 5 p.m. PST | 8 p.m. EST from the American Society of Hematology (ASH) Annual Meeting & Exposition. IMF Chief Medical Officer Dr. Joseph Mikhael and the IMF Support Group Leader Team will share what’s most important to myeloma patients from the latest ASH research. LEARN MORE.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!
